Evidence map›Paper›PMID 35102263›Full record

ReviewInternational journal of impotence research2022

The role of leptin and low testosterone in obesity.

Kajal Khodamoradi, Zahra Khosravizadeh, Deepa Seetharam, Suresh Mallepalli, Natoli Farber, Himanshu Arora

Erratum issuedAbstract readReview
PubMed Publisher
In one paragraph

Review in International journal of impotence research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Endocrine regulation of circadian rhythms.Npj biological timing and sleep · 2025
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 4 countries.

Kajal KhodamoradiDepartment of Urology, Miller School of Medicine, University of Miami, Miami, FL, USA.
Zahra KhosravizadehClinical Research Development Unit, Amiralmomenin Hospital, Arak University of Medical Sciences, Arak, Iran.
Deepa SeetharamDepartment of Urology, Miller School of Medicine, University of Miami, Miami, FL, USA.ORCID http://orcid.org/0000-0002-4886-5025
Suresh MallepalliDepartment of Biotechnology & Bioinformatics, Yogi Vemanan University, Kadapa, India.
Natoli FarberDepartment of Urology, Miller School of Medicine, University of Miami, Miami, FL, USA.
Himanshu AroraDepartment of Urology, Miller School of Medicine, University of Miami, Miami, FL, USA. Hxa287@med.miami.edu.ORCID http://orcid.org/0000-0003-3143-6387
University of Miami · USArak University of Medical Sciences · IRYogi Vemana University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity is a medical condition associated with metabolic disorders and low-grade systemic inflammation. Another characterizing feature of obesity is high circulating levels of leptin (a hormone predominantly made by adipose cells and enterocytes in the small intestine that helps to regulate energy balance), a phenomenon termed hyperleptinemia. Hyperleptinemia is associated with both low-grade systemic inflammation and metabolic dysfunction in obese human beings. Moreover, obesity is associated with low testosterone in men, which correlates with high body fat. The association between leptin and low testosterone could potentially be explained via the imbalanced leptin levels that results in higher estrogen levels, which further increases the aromatase activity. The increase in aromatase activity in turn reciprocally inhibits the testosterone levels and hypothalamic pituitary gonadal axis. Novel strategies are being used to treat obesity, including leptin and testosterone therapy. However, the efficacy and adverse effects of these strategies need further validation through preclinical and clinical studies. Additionally, further studies are needed to establish the molecular mechanism behind leptin-modulated changes to testosterone in obese men. This review summarizes the available literature on the role of leptin and low testosterone during obesity.

Indexed as

LeptinObesityTestosteroneAromataseHumansInflammationMaleAromataseLeptinTestosterone

Identifiers

PMID35102263
OpenAlexW4214591670

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.